CLINICAL_TRIALS
trial_result
· 2010-05-19
Clinical Trial Update: Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia [Phase 3]
Summary
Phase 3 safety and tolerability study of ziprasidone in adolescents with schizophrenia was terminated; results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2010-05-19